# Robert F. Ozols

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/robert-f-ozols/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,812 |
| Field | Ovarian cancer diagnosis and treatment |
| h-index | 72 |
| i10-index | 167 |
| Last Known Institution | Gynecologic Oncology Group |
| OpenAlex ID | https://openalex.org/A5075213038 |
| Works | 265 |

## Researcher papers

- [Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/phase-iii-trial-of-carboplatin-and-paclitaxel-compared-with-cisplatin-and/)
- [Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study](https://scholariq.org/papers/prognostic-factors-for-stage-iii-epithelial-ovarian-cancer-a-gynecologic/)

## Researcher topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)
- [Endometrial and Cervical Cancer Treatments](https://scholariq.org/topics/endometrial-and-cervical-cancer-treatments/)
- [Chemotherapy-induced organ toxicity mitigation](https://scholariq.org/topics/chemotherapy-induced-organ-toxicity-mitigation/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [Gynecologic Oncology Group](https://scholariq.org/institutions/gynecologic-oncology-group/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.